Summary
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Bristol-Myers Squibb(BMS)
Merck
Roche
Major applications as follows:
Melanoma treatment
Bladder cancer treatment
Others
Major Type as follows:
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Bristol-Myers Squibb(BMS)
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Merck
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Roche
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Melanoma treatment
4.1.1 Overview
4.1.2 Melanoma treatment Market Size and Forecast
4.2 Bladder cancer treatment
4.2.1 Overview
4.2.2 Bladder cancer treatment Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market by Type
5.By PD-1 inhibitors
5.1 PD-1 inhibitors
5.1.1 Overview
5.1.2 PD-1 inhibitors Market Size and Forecast
5.2 PD-L1 inhibitors
5.2.1 Overview
5.2.2 PD-L1 inhibitors Market Size and Forecast
5.3 CTLA-4 inhibitors
5.3.1 Overview
5.3.2 CTLA-4 inhibitors Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2018 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2018 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2019-2025 (Volume)
Fig Melanoma treatment Market Size and CAGR 2013-2018 (Million USD)
Fig Melanoma treatment Market Size and CAGR 2013-2018 (Volume)
Fig Melanoma treatment Market Forecast and CAGR 2019-2025 (Million USD)
Fig Melanoma treatment Market Forecast and CAGR 2019-2025 (Volume)
Fig Bladder cancer treatment Market Size and CAGR 2013-2018 (Million USD)
Fig Bladder cancer treatment Market Size and CAGR 2013-2018 (Volume)
Fig Bladder cancer treatment Market Forecast and CAGR 2019-2025 (Million USD)
Fig Bladder cancer treatment Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig PD-1 inhibitors Market Size and CAGR 2013-2018 (Million USD)
Fig PD-1 inhibitors Market Size and CAGR 2013-2018 (Volume)
Fig PD-1 inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Fig PD-1 inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Fig PD-L1 inhibitors Market Size and CAGR 2013-2018 (Million USD)
Fig PD-L1 inhibitors Market Size and CAGR 2013-2018 (Volume)
Fig PD-L1 inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Fig PD-L1 inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Fig CTLA-4 inhibitors Market Size and CAGR 2013-2018 (Million USD)
Fig CTLA-4 inhibitors Market Size and CAGR 2013-2018 (Volume)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2019-2025 (Volume)
